(DD) Dupont De Nemours - Overview
Sector: Basic MaterialsIndustry: Specialty Chemicals | Exchange NYSE (USA) | Currency USD | Market Cap: 19.411m | Total Return 45.3% in 12m
Stock: Semiconductor, Adhesives, Elastomers, Films, Safety
Total Rating 51
Risk 34
Buy Signal -0.22
| Risk 5d forecast | |
|---|---|
| Volatility | 31.3% |
| Relative Tail Risk | -15.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 31.26 |
| Character TTM | |
|---|---|
| Beta | 1.031 |
| Beta Downside | 1.878 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.84% |
| CAGR/Max DD | 0.46 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 220.6191
Description: DD Dupont De Nemours February 24, 2026
DuPont de Nemours, Inc. (NYSE: DD) is a diversified chemicals company that delivers technology-based materials and solutions across six continents. It operates through two primary segments-ElectronicsCo and IndustrialsCo-serving semiconductor fabrication, advanced packaging, OLED displays, automotive and aerospace, water purification, and specialty silicone markets.
In the latest quarter (Q2 2024), DD reported revenue of **$5.6 billion**, up 7 % year-over-year, driven by strong demand for semiconductor-grade dielectrics and OLED-related silicones. Adjusted earnings per share rose to **$2.30**, and free cash flow reached **$1.1 billion**, supporting a **$3 billion** share-repurchase program announced in May. The semiconductor sector remains a key growth engine, with global fab-equipment spending projected to grow **10 % YoY** in 2024, while the OLED display market is expected to expand at a **12 % CAGR** through 2028.
For a deeper dive, consider checking ValueRay’s analysis of DD.
Headlines to watch out for
- Electronics and industrial segment demand impacts revenue
- Water and protection segment growth drives profitability
- Raw material cost fluctuations affect margins
- Regulatory environmental compliance poses financial risk
- Global economic slowdown reduces industrial product sales
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -779.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.54 > 1.0 |
| NWC/Revenue: 29.49% < 20% (prev 12.96%; Δ 16.53% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.41b > Net Income -779.0m |
| Net Debt (2.44b) to EBITDA (1.47b): 1.66 < 3 |
| Current Ratio: 2.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (413.7m) vs 12m ago -1.10% < -2% |
| Gross Margin: 33.16% > 18% (prev 0.32%; Δ 3.28k% > 0.5%) |
| Asset Turnover: 38.10% > 50% (prev 32.91%; Δ 5.19% > 0%) |
| Interest Coverage Ratio: 1.42 > 6 (EBITDA TTM 1.47b / Interest Expense TTM 327.0m) |
Altman Z'' -6.05
| A: 0.15 (Total Current Assets 5.58b - Total Current Liabilities 2.31b) / Total Assets 21.57b |
| B: -1.13 (Retained Earnings -24.28b / Total Assets 21.57b) |
| C: 0.02 (EBIT TTM 465.0m / Avg Total Assets 29.11b) |
| D: -3.32 (Book Value of Equity -24.80b / Total Liabilities 7.47b) |
| Altman-Z'' Score: -6.05 = D |
Beneish M -3.44
| DSRI: 0.83 (Receivables 1.67b/2.20b, Revenue 11.09b/12.06b) |
| GMI: 0.96 (GM 33.16% / 32.00%) |
| AQI: 0.87 (AQ_t 0.58 / AQ_t-1 0.67) |
| SGI: 0.92 (Revenue 11.09b / 12.06b) |
| TATA: -0.10 (NI -779.0m - CFO 1.41b) / TA 21.57b) |
| Beneish M-Score: -3.44 (Cap -4..+1) = AA |
What is the price of DD shares?
As of March 29, 2026, the stock is trading at USD 45.26 with a total of 3,495,913 shares traded.
Over the past week, the price has changed by +6.64%, over one month by -9.19%, over three months by +11.13% and over the past year by +45.33%.
Over the past week, the price has changed by +6.64%, over one month by -9.19%, over three months by +11.13% and over the past year by +45.33%.
Is DD a buy, sell or hold?
Dupont De Nemours has received a consensus analysts rating of 4.45.
Therefore, it is recommended to buy DD.
- StrongBuy: 12
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.7 | 18.7% |
| Analysts Target Price | 53.7 | 18.7% |
DD Fundamental Data Overview March 27, 2026
P/E Trailing = 220.6191
P/E Forward = 18.4502
P/S = 2.8342
P/B = 1.2468
P/EG = 1.7173
Revenue TTM = 11.09b USD
EBIT TTM = 465.0m USD
EBITDA TTM = 1.47b USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 60.0m USD (from shortTermDebt, last quarter)
Debt = 3.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.44b USD (from netDebt column, last quarter)
Enterprise Value = 21.89b USD (19.41b + Debt 3.19b - CCE 715.0m)
Interest Coverage Ratio = 1.42 (Ebit TTM 465.0m / Interest Expense TTM 327.0m)
EV/FCF = 20.29x (Enterprise Value 21.89b / FCF TTM 1.08b)
FCF Yield = 4.93% (FCF TTM 1.08b / Enterprise Value 21.89b)
FCF Margin = 9.73% (FCF TTM 1.08b / Revenue TTM 11.09b)
Net Margin = -7.03% (Net Income TTM -779.0m / Revenue TTM 11.09b)
Gross Margin = 33.16% ((Revenue TTM 11.09b - Cost of Revenue TTM 7.41b) / Revenue TTM)
Gross Margin QoQ = 31.13% (prev 34.96%)
Tobins Q-Ratio = 1.01 (Enterprise Value 21.89b / Total Assets 21.57b)
Interest Expense / Debt = 1.91% (Interest Expense 61.0m / Debt 3.19b)
Taxrate = 21.0% (US default 21%)
NOPAT = 367.4m (EBIT 465.0m * (1 - 21.00%))
Current Ratio = 2.42 (Total Current Assets 5.58b / Total Current Liabilities 2.31b)
Debt / Equity = 0.23 (Debt 3.19b / totalStockholderEquity, last quarter 13.92b)
Debt / EBITDA = 1.66 (Net Debt 2.44b / EBITDA 1.47b)
Debt / FCF = 2.26 (Net Debt 2.44b / FCF TTM 1.08b)
Total Stockholder Equity = 20.68b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.68% (Net Income -779.0m / Total Assets 21.57b)
RoE = -3.77% (Net Income TTM -779.0m / Total Stockholder Equity 20.68b)
RoCE = 1.95% (EBIT 465.0m / Capital Employed (Equity 20.68b + L.T.Debt 3.13b))
RoIC = 1.35% (NOPAT 367.4m / Invested Capital 27.29b)
WACC = 8.47% (E(19.41b)/V(22.61b) * Re(9.61%) + D(3.19b)/V(22.61b) * Rd(1.91%) * (1-Tc(0.21)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.95%
[DCF] Terminal Value 68.57% ; FCFF base≈1.15b ; Y1≈758.0m ; Y5≈346.7m
[DCF] Fair Price = 9.56 (EV 6.35b - Net Debt 2.44b = Equity 3.91b / Shares 408.9m; r=8.47% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 8.37 | EPS CAGR: -14.29% | SUE: 0.28 | # QB: 0
Revenue Correlation: -50.00 | Revenue CAGR: -16.13% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.60 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+8 | Analysts=13
EPS current Year (2026-12-31): EPS=2.30 | Chg7d=+0.001 | Chg30d=+0.001 | Revisions Net=+12 | Growth EPS=+36.8% | Growth Revenue=+3.9%
EPS next Year (2027-12-31): EPS=2.54 | Chg7d=+0.005 | Chg30d=-0.007 | Revisions Net=+10 | Growth EPS=+10.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.80 (9 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.2% (Discount Rate 9.6% - Earnings Yield 0.5%)
[Growth] Growth Spread = -53.5% (Analyst -44.4% - Implied 9.2%)
P/E Forward = 18.4502
P/S = 2.8342
P/B = 1.2468
P/EG = 1.7173
Revenue TTM = 11.09b USD
EBIT TTM = 465.0m USD
EBITDA TTM = 1.47b USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 60.0m USD (from shortTermDebt, last quarter)
Debt = 3.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.44b USD (from netDebt column, last quarter)
Enterprise Value = 21.89b USD (19.41b + Debt 3.19b - CCE 715.0m)
Interest Coverage Ratio = 1.42 (Ebit TTM 465.0m / Interest Expense TTM 327.0m)
EV/FCF = 20.29x (Enterprise Value 21.89b / FCF TTM 1.08b)
FCF Yield = 4.93% (FCF TTM 1.08b / Enterprise Value 21.89b)
FCF Margin = 9.73% (FCF TTM 1.08b / Revenue TTM 11.09b)
Net Margin = -7.03% (Net Income TTM -779.0m / Revenue TTM 11.09b)
Gross Margin = 33.16% ((Revenue TTM 11.09b - Cost of Revenue TTM 7.41b) / Revenue TTM)
Gross Margin QoQ = 31.13% (prev 34.96%)
Tobins Q-Ratio = 1.01 (Enterprise Value 21.89b / Total Assets 21.57b)
Interest Expense / Debt = 1.91% (Interest Expense 61.0m / Debt 3.19b)
Taxrate = 21.0% (US default 21%)
NOPAT = 367.4m (EBIT 465.0m * (1 - 21.00%))
Current Ratio = 2.42 (Total Current Assets 5.58b / Total Current Liabilities 2.31b)
Debt / Equity = 0.23 (Debt 3.19b / totalStockholderEquity, last quarter 13.92b)
Debt / EBITDA = 1.66 (Net Debt 2.44b / EBITDA 1.47b)
Debt / FCF = 2.26 (Net Debt 2.44b / FCF TTM 1.08b)
Total Stockholder Equity = 20.68b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.68% (Net Income -779.0m / Total Assets 21.57b)
RoE = -3.77% (Net Income TTM -779.0m / Total Stockholder Equity 20.68b)
RoCE = 1.95% (EBIT 465.0m / Capital Employed (Equity 20.68b + L.T.Debt 3.13b))
RoIC = 1.35% (NOPAT 367.4m / Invested Capital 27.29b)
WACC = 8.47% (E(19.41b)/V(22.61b) * Re(9.61%) + D(3.19b)/V(22.61b) * Rd(1.91%) * (1-Tc(0.21)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.95%
[DCF] Terminal Value 68.57% ; FCFF base≈1.15b ; Y1≈758.0m ; Y5≈346.7m
[DCF] Fair Price = 9.56 (EV 6.35b - Net Debt 2.44b = Equity 3.91b / Shares 408.9m; r=8.47% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 8.37 | EPS CAGR: -14.29% | SUE: 0.28 | # QB: 0
Revenue Correlation: -50.00 | Revenue CAGR: -16.13% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.60 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+8 | Analysts=13
EPS current Year (2026-12-31): EPS=2.30 | Chg7d=+0.001 | Chg30d=+0.001 | Revisions Net=+12 | Growth EPS=+36.8% | Growth Revenue=+3.9%
EPS next Year (2027-12-31): EPS=2.54 | Chg7d=+0.005 | Chg30d=-0.007 | Revisions Net=+10 | Growth EPS=+10.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.80 (9 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.2% (Discount Rate 9.6% - Earnings Yield 0.5%)
[Growth] Growth Spread = -53.5% (Analyst -44.4% - Implied 9.2%)